Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study

Fatemeh Saberi Hosnijeh, Lina van der Straten, AP Kater, MH van Oers, WFM Posthuma, ME Chamuleau, M Bellido, Jeanette Doorduijn, M Gelder, M Hoogendoorn, F Boer, GD te Raa, JM Kerst, EWA Marijt, RA Raymakers, HR Koene, MR Schaafsma, JA Dobber, SH Tonino, SS KerstingTon Langerak, MD Levin

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)
11 Downloads (Pure)
Original languageEnglish
Pages (from-to)55-60.e6
JournalExperimental Hematology
Publication statusPublished - 2020

Research programs

  • EMC MM-02-72-02
  • EMC OR-01

Cite this